CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade OrthoPediatrics Corp. - KIDS CFD

30.26
2.82%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.12
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

OrthoPediatrics Corp ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 29.43
Open* 29.06
1-Year Change* -39.9%
Day's Range* 29.06 - 30.42
52 wk Range 23.10-53.50
Average Volume (10 days) 220.61K
Average Volume (3 months) 3.27M
Market Cap 662.12M
P/E Ratio -100.00K
Shares Outstanding 23.36M
Revenue 142.11M
EPS -1.01
Dividend (Yield %) N/A
Beta 1.19
Next Earnings Date Feb 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 18, 2024 29.43 0.33 1.13% 29.10 30.23 29.09
Apr 17, 2024 29.87 0.55 1.88% 29.32 30.72 29.32
Apr 16, 2024 30.15 0.59 2.00% 29.56 30.83 29.16
Apr 15, 2024 30.41 -0.22 -0.72% 30.63 31.55 30.15
Apr 12, 2024 31.05 0.21 0.68% 30.84 31.52 30.27
Apr 11, 2024 31.54 0.57 1.84% 30.97 32.26 30.92
Apr 10, 2024 31.69 3.04 10.61% 28.65 31.96 28.65
Apr 9, 2024 30.34 2.47 8.86% 27.87 30.37 27.63
Apr 8, 2024 27.85 0.67 2.47% 27.18 28.29 27.18
Apr 5, 2024 27.42 1.54 5.95% 25.88 28.10 25.88
Apr 4, 2024 26.83 -0.28 -1.03% 27.11 27.85 26.73
Apr 3, 2024 27.36 1.14 4.35% 26.22 27.40 25.80
Apr 2, 2024 26.65 0.75 2.90% 25.90 27.38 25.90
Apr 1, 2024 28.15 -0.25 -0.88% 28.40 28.64 27.74
Mar 28, 2024 29.08 0.31 1.08% 28.77 29.70 28.23
Mar 27, 2024 28.94 2.06 7.66% 26.88 28.97 26.62
Mar 26, 2024 26.18 1.16 4.64% 25.02 26.54 25.02
Mar 25, 2024 26.17 0.40 1.55% 25.77 26.56 25.68
Mar 22, 2024 25.72 0.16 0.63% 25.56 26.56 25.48
Mar 21, 2024 26.47 -0.90 -3.29% 27.37 27.92 26.31

OrthoPediatrics Corp. Events

Time (UTC) Country Event
Monday, April 29, 2024

Time (UTC)

20:00

Country

US

Event

Q1 2024 OrthoPediatrics Corp Earnings Release
Q1 2024 OrthoPediatrics Corp Earnings Release

Forecast

-

Previous

-
Friday, May 24, 2024

Time (UTC)

15:30

Country

US

Event

OrthoPediatrics Corp Annual Shareholders Meeting
OrthoPediatrics Corp Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, June 13, 2024

Time (UTC)

15:30

Country

US

Event

OrthoPediatrics Corp Annual Shareholders Meeting
OrthoPediatrics Corp Annual Shareholders Meeting

Forecast

-

Previous

-
Monday, July 29, 2024

Time (UTC)

20:00

Country

US

Event

Q2 2024 OrthoPediatrics Corp Earnings Release
Q2 2024 OrthoPediatrics Corp Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 122.289 98.049 71.078 72.552 57.559
Revenue 122.289 98.049 71.078 72.552 57.559
Cost of Revenue, Total 31.629 24.646 16.047 17.933 14.879
Gross Profit 90.66 73.403 55.031 54.619 42.68
Total Operating Expense 147.688 116.073 97.833 81.629 67.112
Selling/General/Admin. Expenses, Total 96.933 79.275 64.529 57.211 44.987
Research & Development 8.014 5.543 5.273 5.748 4.732
Unusual Expense (Income) 3.991 0.461 7.324 0.737 0
Operating Income -25.399 -18.024 -26.755 -9.077 -9.553
Interest Income (Expense), Net Non-Operating 23.506 -0.447 -6.932 -3.538 -2.255
Other, Net -1.796 1.083 0.02 -0.07 -0.217
Net Income Before Taxes -3.689 -17.388 -33.667 -12.685 -12.025
Net Income After Taxes 1.258 -16.26 -32.944 -12.685 -12.025
Net Income Before Extra. Items 1.258 -16.26 -32.944 -12.685 -12.025
Total Extraordinary Items 0 0 -1.046
Net Income 1.258 -16.26 -32.944 -13.731 -12.025
Total Adjustments to Net Income 0
Income Available to Common Excl. Extra. Items 1.258 -16.26 -32.944 -12.685 -12.025
Income Available to Common Incl. Extra. Items 1.258 -16.26 -32.944 -13.731 -12.025
Dilution Adjustment
Diluted Net Income 1.258 -16.26 -32.944 -13.731 -12.025
Diluted Weighted Average Shares 20.9477 19.2683 18.0568 14.6242 12.5674
Diluted EPS Excluding Extraordinary Items 0.06005 -0.84388 -1.82446 -0.8674 -0.95684
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS 0.18389 -0.82832 -1.56082 -0.817 -0.95684
Depreciation / Amortization 7.121 6.148 4.66 2.514
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 39.559 31.588 30.994 34.95 32.928
Revenue 39.559 31.588 30.994 34.95 32.928
Cost of Revenue, Total 9.534 8.027 9.77 9.061 7.947
Gross Profit 30.025 23.561 21.224 25.889 24.981
Total Operating Expense 45.145 40.179 39.303 41.911 36.671
Selling/General/Admin. Expenses, Total 32.819 29.882 27.498 27.035 26.977
Research & Development 2.792 2.27 2.034 2.206 1.747
Unusual Expense (Income) 0.001 3.609
Operating Income -5.586 -8.591 -8.309 -6.961 -3.743
Interest Income (Expense), Net Non-Operating 2.01 0.88 0.541 22.302 3.798
Other, Net 0.289 0.331 -0.128 -0.945 -0.827
Net Income Before Taxes -3.287 -7.38 -7.896 14.396 -0.772
Net Income After Taxes -2.886 -6.806 -7.848 18.539 -0.333
Net Income Before Extra. Items -2.886 -6.806 -7.848 18.539 -0.333
Net Income -2.886 -6.806 -7.848 18.539 -0.333
Income Available to Common Excl. Extra. Items -2.886 -6.806 -7.848 18.539 -0.333
Income Available to Common Incl. Extra. Items -2.886 -6.806 -7.848 18.539 -0.333
Diluted Net Income -2.886 -6.806 -7.848 18.539 -0.333
Diluted Weighted Average Shares 22.7047 22.506 20.7066 21.2953 19.7923
Diluted EPS Excluding Extraordinary Items -0.12711 -0.30241 -0.37901 0.87057 -0.01682
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.12711 -0.30241 -0.37898 0.98072 -0.01682
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 226.719 133.648 158.429 128.058 97.156
Cash and Short Term Investments 118.29 53.543 83.899 70.777 60.691
Cash 8.991 7.641 28.758 70.777 60.691
Total Receivables, Net 24.8 17.942 17.549 16.567 9.501
Accounts Receivable - Trade, Net 24.8 17.942 17.212 16.003 8.999
Total Inventory 78.192 57.569 52.989 38 25.708
Prepaid Expenses 3.966 3.229 2.618 1.464 1.256
Total Assets 427.727 304.274 320.412 182.154 112.105
Property/Plant/Equipment, Total - Net 34.286 28.515 27.227 21.349 12.768
Property/Plant/Equipment, Total - Gross 65.09 51.604 44.878 22.635
Accumulated Depreciation, Total -30.804 -23.089 -17.651 -9.867
Intangibles, Net 79.901 69.762 64.245 18.974 2.181
Total Current Liabilities 30.871 29.715 35.028 13.663 9.217
Accounts Payable 11.15 9.325 10.038 6.467 3.971
Accrued Expenses 6.744 5.351 10.882 4.349 3.552
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.144 0.137 0.131 0.124 0.118
Other Current Liabilities, Total 12.833 14.902 13.977 2.723 1.576
Total Liabilities 49.079 78.905 85.644 39.793 30.373
Total Long Term Debt 0.763 0.907 1.044 26.067 21.156
Long Term Debt 0.763 0.907 1.044 26.067 21.156
Total Equity 378.648 225.369 234.768 142.361 81.732
Redeemable Preferred Stock
Common Stock 0.006 0.005 0.005 0.004 0.004
Additional Paid-In Capital 560.81 394.899 388.622 271.182 197.442
Retained Earnings (Accumulated Deficit) -176.768 -178.026 -161.766 -128.822 -115.091
Other Equity, Total -5.4 8.491 7.907 -0.003 -0.623
Total Liabilities & Shareholders’ Equity 427.727 304.274 320.412 182.154 112.105
Total Common Shares Outstanding 22.878 19.6772 19.5603 16.7231 14.5382
Other Current Assets, Total 1.471 1.365 1.374 1.25
Goodwill, Net 86.821 72.349 70.511 13.773
Other Liabilities, Total 11.491 43.512 43.817 0.063
Treasury Stock - Common 0
Cash & Equivalents 109.299 45.902 55.141
Deferred Income Tax 5.954 4.771 5.755
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 226.172 223.255 224.976 226.719 224.558
Cash and Short Term Investments 82.42 93.185 107.73 118.29 120.133
Cash 10.64 9.713 34.656 8.991 35.423
Cash & Equivalents 71.78 83.472 73.074 109.299 84.71
Total Receivables, Net 37.647 33.849 26.838 24.8 26.184
Accounts Receivable - Trade, Net 37.647 33.849 26.838 24.8 26.184
Total Inventory 100.533 90.983 84.922 78.192 74.041
Prepaid Expenses 3.98 3.642 4.005 3.966 2.751
Other Current Assets, Total 1.592 1.596 1.481 1.471 1.449
Total Assets 432.444 434.87 426.29 427.727 430.054
Property/Plant/Equipment, Total - Net 40.236 40.071 36.916 34.286 36.313
Goodwill, Net 80.894 82.911 84.127 86.821 88.044
Intangibles, Net 84.521 88.019 80.271 79.901 81.139
Total Current Liabilities 47.927 44.311 35.218 30.871 28.746
Accounts Payable 22.587 20.89 16.692 11.15 10.881
Accrued Expenses 8.671 8.159 6.242 6.744 6.323
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.15 0.148 0.146 0.144 0.143
Other Current Liabilities, Total 16.519 15.114 12.138 12.833 11.399
Total Liabilities 58.115 54.558 53.135 49.079 46.724
Total Long Term Debt 0.65 0.688 0.725 0.763 0.799
Long Term Debt 0.65 0.688 0.725 0.763 0.799
Deferred Income Tax 5.492 5.564 6.022 5.954 5.457
Other Liabilities, Total 4.046 3.995 11.17 11.491 11.722
Total Equity 374.329 380.312 373.155 378.648 383.33
Common Stock 0.006 0.006 0.006 0.006 0.006
Additional Paid-In Capital 577.54 574.677 562.769 560.81 559.339
Retained Earnings (Accumulated Deficit) -191.051 -186.46 -183.574 -176.768 -168.92
Other Equity, Total -12.166 -7.911 -6.046 -5.4 -7.095
Total Liabilities & Shareholders’ Equity 432.444 434.87 426.29 427.727 430.054
Total Common Shares Outstanding 23.351 23.3405 23.1421 22.878 22.896
Other Long Term Assets, Total 0.621 0.614
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 1.258 -16.26 -32.944 -13.731 -12.025
Cash From Operating Activities -21.766 -13.063 -18.53 -17.769 -15.583
Cash From Operating Activities 13.099 10.68 8.01 4.671 2.892
Non-Cash Items -13.335 6.196 12.113 2.669 3.185
Cash Interest Paid 0.7 0.056 1.233 4.229 2.255
Changes in Working Capital -17.756 -12.551 -4.986 -11.378 -9.635
Cash From Investing Activities -113.371 -7.411 -69.693 -61.922 -5.965
Capital Expenditures -10.031 -16.011 -11.3 -12.086 -5.463
Other Investing Cash Flow Items, Total -103.34 8.6 -58.393 -49.836 -0.502
Cash From Financing Activities 135.974 0.006 46.732 91.019 39.657
Financing Cash Flow Items -3.234 0 0
Issuance (Retirement) of Stock, Net 139.345 0.137 71.857 61.137 43.835
Issuance (Retirement) of Debt, Net -0.137 -0.131 -25.125 29.882 -4.178
Foreign Exchange Effects 0.619 -0.658 -0.404 0.008
Net Change in Cash 1.456 -21.126 -41.895 11.336 18.109
Total Cash Dividends Paid 0 0
Deferred Taxes -5.032 -1.128 -0.723
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -6.806 1.258 9.106 -9.433 -9.1
Cash From Operating Activities -6.461 -21.766 -18.425 -12.367 -4.197
Cash From Operating Activities 3.848 13.099 9.579 6.292 2.961
Deferred Taxes -0.574 -5.032 -4.804 -0.756 -0.317
Non-Cash Items 1.824 -13.335 -14.937 2.401 4.549
Cash Interest Paid 0.011 0.7 0.512 0.06 0.013
Changes in Working Capital -4.753 -17.756 -17.369 -10.871 -2.29
Cash From Investing Activities 32.31 -113.371 -90.144 13.775 14.303
Capital Expenditures -4.94 -10.031 -10.554 -9.465 -4.197
Other Investing Cash Flow Items, Total 37.25 -103.34 -79.59 23.24 18.5
Cash From Financing Activities -0.036 135.974 136.009 27.741 -0.033
Issuance (Retirement) of Stock, Net 139.345 170.345 31.042 0
Issuance (Retirement) of Debt, Net -0.036 -0.137 -31.102 -0.067 -0.033
Foreign Exchange Effects -0.138 0.619 0.426 0.4 0.241
Net Change in Cash 25.675 1.456 27.866 29.549 10.314
Financing Cash Flow Items -3.234 -3.234 -3.234

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

OrthoPediatrics Corp. Company profile

About Orthopediatrics Corp

OrthoPediatrics Corp. is a medical device company, which is designing, developing and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company operates through the OrthoPediatrics Segment, which designs, develops and markets anatomically appropriate implants and devices for children with orthopedic problems. The Company offers a range of products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform Femur, Orthex, QuickPack and ApiFix Mid-C System, to various hospitals and medical facilities throughout the United States and various international markets.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Orthopediatrics Corp revenues increased 38% to $98M. Net loss decreased 51% to $16.3M. Revenues reflect Trauma and Deformity segment increase of 38% to $65.8M, Scoliosis segment increase of 35% to $28M, U.S. segment increase of 24% to $77.8M, International segment increase from $8.1M to $20.3M. Lower net loss reflects Legal settlement expenses decrease of 98% to $150K (expense).

Industry: Medical Devices & Implants

2850 Frontier Drive
WARSAW
INDIANA 46582
US

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

ETH/USD

3,080.87 Price
+0.280% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

17,033.90 Price
-1.950% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

XRP/USD

0.51 Price
+0.180% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,389.39 Price
+0.400% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading